Evidence map›Paper›PMID 28415569›Full record

ArticleOncotarget2017

Interleukin-2-regulatory T cell axis critically regulates maintenance of hematopoietic stem cells.

Sabrina Giampaolo, Gabriela Wójcik, Edgar Serfling, Amiya K Patra

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.7field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Article
  3. Prolonged haematologic toxicity in CAR-T-cell therapy: A review.Journal of cellular and molecular medicine · 2023
    Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Sabrina GiampaoloDepartment of Molecular Pathology, Institute of Pathology, University of Würzburg, Würzburg, Germany.
Gabriela WójcikInstitute of Translational and Stratified Medicine, Peninsula Schools of Medicine and Dentistry, University of Plymouth, Plymouth, UK.
Edgar SerflingDepartment of Molecular Pathology, Institute of Pathology, University of Würzburg, Würzburg, Germany.
Amiya K PatraDepartment of Molecular Pathology, Institute of Pathology, University of Würzburg, Würzburg, Germany.
University of Würzburg · DEComprehensive Cancer Center Mainfranken · DEUniversity of Plymouth · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The role of IL-2 in HSC maintenance is unknown. Here we show that Il2-/- mice develop severe anomalies in HSC maintenance leading to defective hematopoiesis. Whereas, lack of IL-2 signaling was detrimental for lympho- and erythropoiesis, myelopoiesis was enhanced in Il2-/- mice. Investigation of the underlying mechanisms of dysregulated hematopoiesis in Il2-/- mice shows that the IL-2-Treg cell axis is indispensable for HSC maintenance and normal hematopoiesis. Lack of Treg activity resulted in increased IFN-γ production by activated T cells and an expansion of the HSCs in the bone marrow (BM). Though, restoring Treg population successfully rescued HSC maintenance in Il2-/- mice, preventing IFN-γ activity could do the same even in the absence of Treg cells. Our study suggests that equilibrium in IL-2 and IFN-γ activity is critical for steady state hematopoiesis, and in clinical conditions of BM failure, IL-2 or anti-IFN-γ treatment might help to restore hematopoiesis.

Indexed as

AnimalsBiomarkersCell Self RenewalHematopoiesisHematopoietic Stem CellsImmunophenotypingInterferon-gammaInterleukin-10Interleukin-2Lymphocyte ActivationMiceMice, KnockoutSignal TransductionT-Lymphocytes, RegulatoryBiomarkersInterferon-gammaInterleukin-10Interleukin-2hematopoietic stem cellsIFN-γIL-10IL-2Immune responseImmunityImmunology and Microbiology SectionTreg cells

Identifiers

PMID28415569
PMCPMC5444691
OpenAlexW2595859136

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.